These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32939795)

  • 21. [Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine].
    Wagner G; Sachse MM
    Hautarzt; 2014 Jun; 65(6):548-52. PubMed ID: 24452843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subacute cutaneous lupus erythematosus associated with radioiodine treatment.
    Abbott RA; May K; Motley RJ
    Clin Exp Dermatol; 2012 Oct; 37(7):753-4. PubMed ID: 22369225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
    Wiznia LE; Subtil A; Choi JN
    JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus.
    Geraminejad P; Stone MS; Sontheimer RD
    Lupus; 2004; 13(6):473-7. PubMed ID: 15303576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subacute cutaneous lupus erythematosus: a case report of Polypodium leucotomos as an adjuvant therapy.
    Breithaupt AD; Jacob SE
    Cutis; 2012 Apr; 89(4):183-4. PubMed ID: 22611747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced Subacute Cutaneous Lupus Erythematosus Caused by a Topical Beta Blocker - Timolol.
    Bilewicz-Stebel M; Miziołek B; Bergler-Czop B; Stańkowska A
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):44-47. PubMed ID: 29782299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy.
    Funke AA; Kulp-Shorten CL; Callen JP
    Arch Dermatol; 2010 Oct; 146(10):1113-6. PubMed ID: 20956642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature.
    Khorasanchi A; Korman AM; Manne A; Meara A
    Front Med (Lausanne); 2024; 11():1334718. PubMed ID: 38362536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced subacute cutaneous lupus erythematosus related to doxycycline.
    Miller KK; Chu J; Patel R; Kamino H
    Dermatol Online J; 2011 Oct; 17(10):3. PubMed ID: 22031629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced cutaneous lupus erythematosus: 88 new cases.
    Laurinaviciene R; Sandholdt LH; Bygum A
    Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients.
    Callen JP; Klein J
    Arthritis Rheum; 1988 Aug; 31(8):1007-13. PubMed ID: 3261587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subacute cutaneous lupus erythematosus presenting as erythroderma.
    Kalavala M; Shah V; Blackford S
    Clin Exp Dermatol; 2007 Jul; 32(4):388-90. PubMed ID: 17459074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced subacute cutaneous lupus erythematosus.
    Callen JP
    Lupus; 2010 Aug; 19(9):1107-11. PubMed ID: 20693204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity.
    Evans KG; Heymann WR
    Cutis; 2013 Jan; 91(1):25-9. PubMed ID: 23461055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.